US20170121342A1

Heterocyclic modulators of hif activity for treatment of disease

University of Texas System

Abstract

The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.

University: University of Texas System
Assignee: Board Of Regents, University Of Texas System
Inventor: Philip Jones
Priority date: August 24, 2012
Filing date: October 04, 2016
Publication date: May 04, 2017
Language: en
PDF source: https://patentimages.storage.googleapis.com/c2/a1/a3/adc88ff5de7e5f/US20170121342A1.pdf
Metadata fetched: August 29, 2026 00:24